ABL Bio (XKRX:298380) Beginning Cash Position : ₩28,064 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Beginning Cash Position?

ABL Bio's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₩28,064 Mil.

ABL Bio's quarterly Beginning Cash Position increased from Sep. 2023 (₩15,935 Mil) to Dec. 2023 (₩27,471 Mil) and increased from Dec. 2023 (₩27,471 Mil) to Mar. 2024 (₩28,064 Mil).

ABL Bio's annual Beginning Cash Position declined from Dec. 2021 (₩40,658 Mil) to Dec. 2022 (₩21,589 Mil) but then increased from Dec. 2022 (₩21,589 Mil) to Dec. 2023 (₩25,136 Mil).

ABL Bio Beginning Cash Position Historical Data

The historical data trend for ABL Bio's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Beginning Cash Position Chart

ABL Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

122,034.75

91,146.34

40,658.31

21,588.58

25,135.63

ABL Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															25,135.63	31,248.78	15,934.74	27,470.86	28,064.22

ABL Bio Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

ABL Bio Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of ABL Bio's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio (XKRX:298380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

https://www.ablbio.com

ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines